T cells can be reprogrammed with transgenic antigen recognition receptors, including chimeric antigen receptors and T cell receptors, to selectively recognize and kill cancer cells.
This EMBO workshop will bring together experts in the editing space, who are studying the CRISPR-Cas immune defence system, developing novel and safer editing approaches, and applying them to the clinic.
Preferences
Would you like to share some personal information with us so we can improve your experience on Researchalize.org?
